Mikael Alsterholm

Summary

Affiliation: Sahlgrenska University Hospital
Country: Sweden

Publications

  1. ncbi Frequency of bacteria, Candida and malassezia species in balanoposthitis
    Mikael Alsterholm
    Department of Dermatology and Venereology, Sahlgrenska University Hospital, Goteborg, Sweden
    Acta Derm Venereol 88:331-6. 2008
  2. ncbi Fusidic acid-resistant Staphylococcus aureus in impetigo contagiosa and secondarily infected atopic dermatitis
    Mikael Alsterholm
    Department of Dermatology and Venereology, Sahlgrenska University Hospital, SE 413 45 Goteborg, Sweden
    Acta Derm Venereol 90:52-7. 2010
  3. ncbi Antimicrobial activity of topical skin pharmaceuticals - an in vitro study
    Mikael Alsterholm
    Department of Dermatology and Venereology, Sahlgrenska University Hospital, SE 413 45 Goteborg, Sweden
    Acta Derm Venereol 90:239-45. 2010

Detail Information

Publications3

  1. ncbi Frequency of bacteria, Candida and malassezia species in balanoposthitis
    Mikael Alsterholm
    Department of Dermatology and Venereology, Sahlgrenska University Hospital, Goteborg, Sweden
    Acta Derm Venereol 88:331-6. 2008
    ..Different microbes did not correspond with distinct clinical manifestations. In summary, we report increased frequency of microbes, specifically S. aureus, in the area of the prepuce and glans penis in balanoposthitis...
  2. ncbi Fusidic acid-resistant Staphylococcus aureus in impetigo contagiosa and secondarily infected atopic dermatitis
    Mikael Alsterholm
    Department of Dermatology and Venereology, Sahlgrenska University Hospital, SE 413 45 Goteborg, Sweden
    Acta Derm Venereol 90:52-7. 2010
    ..FRSA levels were persistently low in AD. Continued restrictive use of topical fusidic acid is advised to limit an increase in FRSA levels in dermatology patients...
  3. ncbi Antimicrobial activity of topical skin pharmaceuticals - an in vitro study
    Mikael Alsterholm
    Department of Dermatology and Venereology, Sahlgrenska University Hospital, SE 413 45 Goteborg, Sweden
    Acta Derm Venereol 90:239-45. 2010
    ..With the global threat of multi-resistant bacteria there is a need for new, topical, non-resistance-promoting, antimicrobial preparations for the treatment of skin infections...